
    
      This study aims to explore the efficacy and safety of chemotherapy or chemotherapy plus the
      PD-1 antibody in RET Fusion Positive Advanced Non-small Cell Lung Cancer. We aim to enrolled
      100 patients in this study, the primary endpoint was PFS.
    
  